N

NovaBay Pharmaceuticals Inc
XBER:B9P

Watchlist Manager
NovaBay Pharmaceuticals Inc
XBER:B9P
Watchlist
Price: 0.114 EUR -11.63% Market Closed
Market Cap: 480.5k EUR

Wall Street
Price Targets

B9P Price Targets Summary
NovaBay Pharmaceuticals Inc

There are no price targets for B9P.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
NovaBay Pharmaceuticals Inc Competitors:
Price Targets
NAVA
Navamedic ASA
68% Upside
MVP
Medical Developments International Ltd
59% Upside
OCS
Oculis Holding AG
88% Upside
4151
Kyowa Kirin Co Ltd
7% Upside
SUPRIYA
Supriya Lifescience Ltd
17% Upside
053030
Binex Co Ltd
93% Upside

Revenue
Forecast

Revenue Estimate
NovaBay Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for NovaBay Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 2 years is 13%.

16%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
NovaBay Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
NovaBay Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is B9P's stock price target?
Not Available

B9P doesn't have any price targets made by Wall Street professionals.

What is NovaBay Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for NovaBay Pharmaceuticals Inc's revenue is 16%. The projected CAGR for the next 2 years is 13%.

Back to Top